Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenxin Luo

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Journal for Immunotherapy of Cancer|June 10, 2022
Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockadeFei Ju, Yong Luo, Chaolong Lin, et al.
Nature Communications|November 21, 2024
A potent broad-spectrum neutralizing antibody targeting a conserved region of the prefusion RSV F proteinYongpeng Sun, Liqin Liu, Hongsheng Qiang, et al.
Precision Clinical Medicine|April 11, 2025
Early-stage lung cancer detection via thin-section low-dose CT reconstruction combined with AI in non-high risk populations: a large-scale real-world retrospective cohort studyGuiyi Ji, Wenxin Luo, Yuan Zhu, et al.
The New England Journal of Medicine|August 30, 2023
Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal CancerTingdong Li, Fugui Li, Xiaoyi Guo, et al.
Cancer Research|June 6, 2025
Comprehensive Characterization of Somatic Mutation Timing Reveals the Evolutionary Trajectory of Lung Adenocarcinoma in Chinese PatientsNa Qin, Zhoufeng Wang, Xianfeng Xu, et al.
Signal Transduction and Targeted Therapy|February 14, 2024
Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccinesWenxin Luo, Jiadi Gan, Zhu Luo, et al.
Science Translational Medicine|January 14, 2026
An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivoYongpeng Sun, Liqin Liu, Zemin Jiang, et al.
Science Translational Medicine|October 20, 2017
A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B virusesChenguang Shen, Junyu Chen, Rui Li, et al.
Cell Host & Microbe|February 4, 2021
Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoatingLongfa Xu, Qingbing Zheng, Rui Zhu, et al.
Cell Host & Microbe|August 24, 2022
Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktailQingbing Zheng, Rui Zhu, Zhichao Yin, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Journal for Immunotherapy of Cancer|June 10, 2022
Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockadeFei Ju, Yong Luo, Chaolong Lin, et al.
Nature Communications|November 21, 2024
A potent broad-spectrum neutralizing antibody targeting a conserved region of the prefusion RSV F proteinYongpeng Sun, Liqin Liu, Hongsheng Qiang, et al.
Precision Clinical Medicine|April 11, 2025
Early-stage lung cancer detection via thin-section low-dose CT reconstruction combined with AI in non-high risk populations: a large-scale real-world retrospective cohort studyGuiyi Ji, Wenxin Luo, Yuan Zhu, et al.
The New England Journal of Medicine|August 30, 2023
Anti-Epstein-Barr Virus BNLF2b for Mass Screening for Nasopharyngeal CancerTingdong Li, Fugui Li, Xiaoyi Guo, et al.
Cancer Research|June 6, 2025
Comprehensive Characterization of Somatic Mutation Timing Reveals the Evolutionary Trajectory of Lung Adenocarcinoma in Chinese PatientsNa Qin, Zhoufeng Wang, Xianfeng Xu, et al.
Signal Transduction and Targeted Therapy|February 14, 2024
Safety, immunogenicity and protective effectiveness of heterologous boost with a recombinant COVID-19 vaccine (Sf9 cells) in adult recipients of inactivated vaccinesWenxin Luo, Jiadi Gan, Zhu Luo, et al.
Science Translational Medicine|January 14, 2026
An antibody cocktail targeting conserved, nonoverlapping epitopes prevents viral escape and confers protection against RSV in vivoYongpeng Sun, Liqin Liu, Zemin Jiang, et al.
Science Translational Medicine|October 20, 2017
A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B virusesChenguang Shen, Junyu Chen, Rui Li, et al.
Cell Host & Microbe|February 4, 2021
Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoatingLongfa Xu, Qingbing Zheng, Rui Zhu, et al.
Cell Host & Microbe|August 24, 2022
Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktailQingbing Zheng, Rui Zhu, Zhichao Yin, et al.
Pageof 12